Skip to main navigation menu Skip to main content Skip to site footer
Banner La Barca de Teseo revista UASD

Artículos

Vol. 3 No. 1 (2025): La Barca de Teseo

Adherencia al tratamiento de hipertensión arterial en pacientes mayores de 40 años en una Unidad de Atención Primaria en República Dominicana

DOI
https://doi.org/10.61780/bdet.v3i1.50
Submitted
May 16, 2024
Published
2025-03-11

Abstract

INTRODUCTION: arterial hypertension is the main cardiovascular risk factor. Adherence is challenged by socioeconomic factors; worldwide, only 21% of adults adhere correctly to their treatment. The study poses the following PIO format question: What are the main causes associated with non-adherence to antihypertensive treatment in patients over 40 years of age at the Primary Care Unit of the El Llano community, Baní, during February - March 2024? OBJECTIVES: to describe the causes of non-adherence to hypertension treatment; identify the age group with the highest adherence to hypertension treatment; evaluate adherence to pharmacological treatment for hypertension by sex; establish the relationship between non-adherence to hypertension treatment and educational level. METHODOLOGY: observational, prospective, cross-sectional, analytical-descriptive. The study will be reported following the STROBE guide criteria. RESULTS: patients over 60 years of age led adherence to treatment with 60%, and women constituted 59.12% of the total adherent population. Forgetfulness and economic limitations were the main barriers to adherence. Primary education was predominant among the most adherent patients. CONCLUSIONS: women over 60 years of age with primary education showed the highest adherence. RECOMMENDATION: to promote education on hypertension, family support, and access to medication.

References

  1. Asgedom, S. W., Atey, T. M., & Desse, T. A. (2018). Antihypertensive medication adherence and associated factors among adult hypertensive patients at Jimma University Specialized Hospital, southwest Ethiopia. BMC Research Notes, 11(1), 27. https://doi.org/10.1186/s13104-018-3139-6
  2. Centers for Disease Control and Prevention. (s.f.). Epi InfoTM. https://www.cdc.gov/epiinfo/esp/es_index.html
  3. Conte, E., Morales, Y., Niño, C., Zamorano, C., Benavides, M., Donato, M., et al. (2020). La adherencia a los medicamentos en pacientes hipertensos y en muestra de la población general. Revista OFIL·ILAPHAR, 30(4), 313–323. https://doi.org/10.4321/s1699-714x2020000400011
  4. Nashilongo, M. M., Singu, B., Kalemeera, F., Mubita, M., Naikaku, E., Baker, A., Ferrario, A., Godman, B., Achieng, L., & Kibuule, D. (2017). Assessing adherence to antihypertensive therapy in primary health care in Namibia: Findings and implications. Cardiovascular Drugs and Therapy, 31(5–6), 565–578. https://doi.org/10.1007/s10557-017-6756-8
  5. Navas Santos, L., Nolasco Monterroso, C., Carmona Moriel, C. E., López Zamorano, M. D., Santamaría Olmo, R., & Crespo Montero, R. (2016). Relación entre la ingesta de sal y la presión arterial en pacientes hipertensos. Enfermería Nefrológica, 19(1). https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2254-28842016000100003
  6. Organización Mundial de la Salud. (s.f.). Hipertensión. https://www.paho.org/es/temas/hipertension
  7. Pagès-Puigdemont, N., & Valverde-Merino, M. I. (2018). Adherencia terapéutica: factores modificadores y estrategias de mejora. Ars Pharmaceutica, 59(4), 251–258. https://doi.org/10.30827/ars.v59i4.7357
  8. Pagès-Puigdemont, N., & Valverde-Merino, M. I. (2018). Métodos para medir la adherencia terapéutica. Ars Pharmaceutica, 59(3), 163–172. https://revistaseug.ugr.es/index.php/ars/article/view/7387
  9. Ramírez, P. A. R., Ramírez, P. J. F., & Borrell, Z. J. C. (2020). Adherencia terapéutica antihipertensiva y factores asociados al incumplimiento en el primer nivel de atención en Cienfuegos, 2019. Revista Cubana de Farmacia, 53(1), 1–19.
  10. Stanikzai, M. H., Wafa, M. H., Tawfiq, E., Jafari, M., Le, C. N., Wasiq, A. W., Rahimi, B. A., Baray, A. H., Ageru, T. A., & Suwanbamrung, C. (2023). Predictors of non-adherence to antihypertensive medications: A cross-sectional study from a regional hospital in Afghanistan. PLoS ONE, 18(12), e0295246. https://doi.org/10.1371/journal.pone.0295246
  11. Uchmanowicz, I., Jankowska-Polańska, B., Chudiak, A., Szymańska-Chabowska, A., & Mazur, G. (2016). Psychometric evaluation of the Polish adaptation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. BMC Cardiovascular Disorders, 16, 87. https://doi.org/10.1186/s12872-016-0270-y
  12. Woode, E., Boakye-Gyasi, E., Obirikorang, Y., Adu, E. A., Obirikorang, C., Acheampong, E., & Odame-Anto, E. (2022). Predictors of medication nonadherence among hypertensive clients in a Ghanaian population: Application of the Hill-Bone and Perceived Barriers to Treatment Compliance Scale. Health Science Reports, 5(3), e584. https://doi.org/10.1002/hsr2.584
  13. World Health Organization. (s.f.). Hypertension. https://www.who.int/news-room/fact-sheets/detail/hypertension